FDA Inspection 970804 — Merz Pharma Gmbh & Co. KGaA
The FDA completed an inspection of Merz Pharma Gmbh & Co. KGaA on Apr 29, 2016 in Reinheim. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 29, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Reinheim (Germany)